# KATERZIA
> **NDA211340** · New Drug Application · Sponsor: AZURITY · Approved 2019-07-08
## Drug
- **FDA Application Number:** NDA211340
- **Application type:** New Drug Application
- **Brand name:** KATERZIA
- **Generic name:** AMLODIPINE
- **Active ingredients:** AMLODIPINE BENZOATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc.
- **First approval:** 2019-07-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211340)
---
*AI Analytics · CC0 1.0*